Thinking impaired in COVID-19 survivors, study finds
August 2, 2021
In a sample of more than 400 older adults in Argentina who had recovered from COVID-19, more than 60% displayed some degree of cognitive impairment.
Category
August 2, 2021
In a sample of more than 400 older adults in Argentina who had recovered from COVID-19, more than 60% displayed some degree of cognitive impairment.
July 28, 2021
Could your new home with its fresh paint, carpet and cabinets, as well as pesticides used around the place, cause a range of illnesses due to chemical intolerance? A new paper provides a long-awaited link between exposures to common chemicals and so-called unexplained illnesses. It also for the first time asserts a mechanism for the how and why this happens – a two-stage disease process called toxicant-induced loss of tolerance, or TILT.
July 27, 2021
Researchers at UT Health San Antonio, The University of Washington at Seattle and the Icahn School of Medicine at Mount Sinai in New York have launched NIRVANA, a National Institutes of Health-funded pilot clinical study to treat acute kidney injury (AKI) in COVID-19 patients.
July 8, 2021
Researchers from UT Health San Antonio and colleagues worldwide describe a new science-based intervention for hiccups in a research letter published in the journal JAMA Network Open.
July 1, 2021
In a U.S. and Swiss study, nearly all patients with cancer developed good immune response to the COVID-19 mRNA vaccines three to four weeks after receiving their second dose, but the fact that a small group of the patients exhibited no response raised questions about how their protection against the virus will be addressed moving forward.
June 28, 2021
Our biochemistry team learns more about how the coronavirus disguises itself in the body.